SLC13A2 belongs to the solute carrier family 13 that includes transporters for di- and tricarboxylates as well as sulfate. SLC13A2 seems to play a crucial role in the regulation of urinary citrate concentrations. And low urinary citrate concentrations or hypocitraturia are usually associated with an increased risk of kidney-stone formation. Moreover, SLC13A2 may also affect longevity or metabolic status.
|Basic Information of SLC13A2|
|Protein Name||Solute carrier family 13 member 2|
|Gene Name||SLC13A2/ NADC1/SDCT1|
|Aliases||Na(+)/dicarboxylate cotransporter 1 (NaDC-1), Renal sodium/dicarboxylate cotransporter|
|Organism||Homo sapiens (Human)|
SLC13A2/NaDC2 is an important protein in human. This protein influences cotransport of sodium ions and dicarboxylates such as succinate and citrate. It also participates in many molecular functions, including low-affinity sodium (dicarboxylate symporter activity) and transporter activity. Anion transmembrane transport activity is an important biological progress under the direction of SLC13A2.
Fig.1 Schema for the metabolism of citrate in a proximal tubule cell. (Dogliotti, 2013)
This article identifies that there is an epistatic interaction between VDR and SLC13A2 alleles in the pathogenesis of idiopathic hypocitraturia in calcium-oxalate SF.
This article suggests that in the human kidney, apical NaDC1 immunolabel is presented throughout the entire proximal tubule and is not detectable in other renal cells; NaDC1 immunolabel is not presented in renal tumors. These results provide important information regarding NaDC1's role in human dicarboxylate metabolism.
This review shows that patients with AA genotypes are more susceptible to hypocitraturia than those with GG, hence carrying a higher risk for kidney stone recurrence.
This article shows the present results are not able to demonstrate rs11568476 mutation of SLC13A2 gene as a possible genetic factor for development of hypocitraturia in patients with calcium containing kidney renal stone disease.
Membrane protein studies have got great progress over the past few years. Based on our versatile Magic™ membrane protein production platform, we can provide a series of membrane protein preparation services in reconstitution forms as well as multiple active formats for worldwide customers. Besides, aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC13A2 antibody development services.
During the past years, Creative Biolabs has successfully generated many functional membrane proteins for our global customers. It’s our pleasure to boost the development of our clients’ programs with our one-stop, custom-oriented service. For more detailed information, please feel free to contact us.